Skip to main content
GutCited

Fructooligosaccharides (FOS) 관련 Chronic Constipation

C

Some studies show increased stool frequency. Bifidogenic effect well-established but clinical laxation effect more modest than inulin.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'ingredient\u003Dfructooligosaccharides\u0026condition\u003Dconstipation'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

C

결론

Some studies show increased stool frequency. Bifidogenic effect well-established but clinical laxation effect more modest than inulin.

Key Study Findings

Review
Prebiotics and Gut Health: Mechanisms, Clinical Evidence, and Future Directions.
Dose: None vs: None Outcome: gut health outcomes including microbiota modulation and SCFA … 효과: None None

대상 집단: healthy individuals, children, elderly, and those with constipation, metabolic syndrome, or dysbiosis

Randomized Controlled Trial n=67 4 weeks Double-blind
Effects and Persistence of Bifidobacterium animalis subsp. lactis BL-99 and Fructooligosaccharides on Older Adults with …
Dose: None vs: Placebo Outcome: Weekly spontaneous bowel movements 효과: 4.94 vs 3.00 (P<0.001) P<0.001

대상 집단: Older adults >=60 with functional constipation (Rome IV)

Other
Maternal or post-weaning dietary fructo-oligosaccharide supplementation reduces stillbirth rate of sows and diarrhea of weaned …
Dose: 2 g vs: None Outcome: Constipation symptoms 효과: None P < 0.05

대상 집단: Constipation patients

Randomized Controlled Trial Double-blind
Xylo-oligosaccharides improve functional constipation by targeted enrichment of Bifidobacterium.
Dose: 6 g vs: Placebo Outcome: Constipation symptoms 효과: None None

대상 집단: Constipation patients

Systematic Review
Fructooligosaccharides for Relieving Functional Constipation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Dose: None vs: None Outcome: Constipation symptoms 효과: OR: 10.36 p < 0.00001

대상 집단: Constipation patients

Randomized Controlled Trial Double-blind
Advice to People with Parkinson's in My Clinic: Probiotics and Prebiotics.
Dose: None vs: Placebo Outcome: Constipation symptoms 효과: None None

대상 집단: Constipation patients

Key Statistics

4

연구

350

참여자

Positive

C

등급

Referenced Papers

Journal of physiology … 2009 312 인용
Journal of the … 2007 84 인용
BioFactors (Oxford, England) 2004 48 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:
2-10 g/day
prebioticeffect:
5-8 g/day for bifidogenic effect
constipationsupport:
5-10 g/day

상한량: Well-tolerated up to 20 g/day; start low to avoid excess gas

연구에서 사용된 용량

용량 기간 효과 N
None -- Positive --
None 4 weeks Positive 67
2 g -- Neutral --
6 g -- Positive --
None -- Positive --
None -- Positive --
None -- Mixed --
None -- Positive --

권장 복용 시간: With meals; divide doses throughout the day

Safety & Side Effects

보고된 부작용

  • Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day)
  • Abdominal cramping at higher doses
  • May worsen IBS symptoms in FODMAP-sensitive individuals
  • Loose stools at excessive doses

알려진 상호작용

  • Other FODMAPs (cumulative fermentation effect in sensitive individuals)
  • Blood sugar-lowering medications (FOS may modestly affect glycemic response)
  • Calcium supplements (FOS may enhance calcium absorption)

일일 최대 섭취 허용량: Well-tolerated up to 20 g/day; start low to avoid excess gas

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does Fructooligosaccharides (FOS) help with Chronic Constipation?
Based on 4 studies with 350 participants, there is limited but promising evidence that Fructooligosaccharides (FOS) may support Chronic Constipation management. Our evidence grade is C (Some Evidence).
How much Fructooligosaccharides (FOS) should I take for Chronic Constipation?
Studies have used various dosages. A commonly studied range is 2-10 g/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Fructooligosaccharides (FOS)?
Reported side effects may include Gas, bloating, and flatulence (dose-dependent; more common above 10 g/day), Abdominal cramping at higher doses, May worsen IBS symptoms in FODMAP-sensitive individuals, Loose stools at excessive doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Fructooligosaccharides (FOS) and Chronic Constipation?
We rate the evidence as Grade C (Some Evidence). This rating is based on 4 peer-reviewed studies with 350 total participants. The overall direction of effect is positive.

Related Evidence

관련 다른 성분: Chronic Constipation

Fructooligosaccharides (FOS) 다른 건강 상태에 대한 근거

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.